Cost-effectiveness analysis of Belimumab in patients with systemic lupus erythematosus in Spain

Objective: To estimate the cost-effectiveness of belimumab in patients with systemic lupus erythematosus (SLE) presenting positive biomarkers and active disease despite standard treatment (ST), from the Spanish social perspective. Methods: A microsimulation model was used to estimate the cost-effect...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Silvia Díaz-Cerezo (Autor), Ángel María García-Aparicio (Autor), Javier Parrondo (Autor), Laura Amanda Vallejo-Aparicio (Autor)
Format: Knjiga
Izdano: Elsevier, 2015-02-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno